N-末端B型脑钠肽前体与糖尿病肾病的相关性(2)
 |
| 第1页 |
参见附件。
[3]Yano Y,Katsuki A,Gabazza EC,et al.Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microallbuminuria[J].J Clin Endocrinol Metab,1999,84:2253-2356.
[4]Siebenhofer A,Ng LL,Plank J,et al.B-type natriuretic peptide in type 1 diabetic patients with and without diabetic nephropathy.Diabetic Med,2003,20:523-539.
[5]Liu C,Agnes G,Corcuff JB,et al.B-type natriuretic peptide in diabetes mellitus:the influence of chronic renal failure and meal[J].Diabetes Care,2005,28:752.
[6]Mckenna K,Smith D,Moore K,et al.Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in type 1 diabetes mellitus[J].Diabet Med,2001,18:973-978.
[7]随华,刘纯,李秀娟.2型糖尿病肾功能减退对血浆脑钠肽质量浓度的影响[J].中国实用内科杂志,2007,27(7):516-518.
[8]徐滨华,吴东红,苏雁,等.脑利尿钠肽、同型半胱氨酸与2型糖尿病早期肾病的关系及血糖变化的影响[J].现代生物医学进展,2010,10(17):3319-3321.
[9]Mikino H,Mukoyama M,MORI K,et al.Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice[J].Diabetologia,2006,49(10):2514-2524.
[10]Yano Y,Katsuki A,Gabasza EC,et al.Plasma levels of brain natriuretic peptide are correlated with rennin activity in normotensive type 2 diabetic patients[J].Diabetes Care,2000,23(12):1853-1855.
[11]李景兰.β2-MG、IgG、GAL检测与2型糖尿病肾病的关系[J].中国医学创新，2010，7(3):129.
[12]郭海旺.糖尿病肾病患者肾组织结构的变化及防治[J].中国医学创新，2010，7(7):164-165.
【收稿日期】2011-09-24
您现在查看是摘要介绍页，详见PDF附件。